Close Menu

NEW YORK (GenomeWeb) – Life sciences informatics company Benchling said today that it has closed a $14.5 million Series B round of venture capital. Benchmark led the round, with participation from Fidelity Investments' F-Prime Capital and previous investor Thrive Capital.

As as result of the investment, Benchmark General Partner Eric Vishria is joining the board of San Francisco-based Benchling. He touted the rise of biologics as a major factor in backing Benchling.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.